Vis enkel innførsel

dc.contributor.authorLilleborge, Marie
dc.contributor.authorFalk, Ragnhild Sørum
dc.contributor.authorRussnes, Hege Elisabeth Giercksky
dc.contributor.authorSauer, Torill
dc.contributor.authorUrsin, Giske
dc.contributor.authorHofvind, Solveig
dc.date.accessioned2020-03-09T13:00:56Z
dc.date.accessioned2020-03-20T23:32:28Z
dc.date.available2020-03-09T13:00:56Z
dc.date.available2020-03-20T23:32:28Z
dc.date.issued2019-05-13
dc.identifier.citationLilleborge M, Falk R, Russnes HE, Sauer T, Ursin G, Hofvind S. Risk of breast cancer by prior screening results among women participating in BreastScreen Norway. Cancer. 2019;125(19):3330-3337en
dc.identifier.issn0008-543X
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/10642/8294
dc.description.abstractBackground: This registry‐based cohort study followed women who participated in the organized breast cancer screening program in Norway, BreastScreen Norway, in 1995‐2016. Incidence rates and incidence rate ratios were used to estimate absolute and relative risks of breast cancer associated with PSRs. Histopathological characteristics of subsequent breast cancers were presented by PSRs. Results: This study included 762,643 women with up to 21 years of follow‐up. In comparison with negatively screened women, increased incidence rate ratios of 1.8, 2.0, 2.9, and 3.8 were observed after negative additional imaging, for benign biopsy, for hyperplasia with atypia, and for carcinoma in situ, respectively. Subsequent breast cancers did not differ in tumor diameter or histological grade, whereas the proportion of lymph node–positive breast cancers decreased as the presumed malignancy potential of PSRs increased. Conclusions: The risk of subsequent breast cancer increased with the presumed malignancy potential of PSRs, whereas the tumor characteristics of subsequent cancers did not differ except for the lymph node status. Women with screen‐detected benign lesions or hyperplasia with atypia might benefit from more frequent screening.en
dc.description.sponsorshipThis work was funded by the Norwegian Cancer Society (grant 5746604).en
dc.language.isoenen
dc.publisherWileyen
dc.relation.ispartofseriesCancer;Volume 125, Issue 19
dc.rightsThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.en
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectBreast canceren
dc.subjectBreast carcinoma in situen
dc.subjectBreast diseasesen
dc.subjectEarly cancer detectionen
dc.subjectMammographyen
dc.subjectRisk assessmentsen
dc.titleRisk of breast cancer by prior screening results among women participating in BreastScreen Norwayen
dc.typeJournal articleen
dc.typePeer revieweden
dc.date.updated2020-03-09T13:00:56Z
dc.description.versionpublishedVersionen
dc.identifier.doihttps://dx.doi.org/10.1002/cncr.32330
dc.identifier.cristin1711403
dc.source.journalCancer
dc.relation.projectIDKreftforeningen: 5746604


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Med mindre annet er angitt, så er denne innførselen lisensiert som This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.